Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salvage Treatment or Active Clinical Surveillance for Oligometastatic Prostate Cancer: a Randomized Phase II Trial

NCT01558427 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01558427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01558427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salvage Treatment or Active Clinical Surveillance for Oligometastatic Prostate Cancer: a Randomized Phase II Trial
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2012
Completion date
August 15, 2023
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer